ACR Meeting Abstracts
Abstract Number: 855 • ACR/ARHP Annual Meeting 2018
Giorgia Grosso1, Natalie Sippl2, Barbro Kjellström3, Khaled Amara2, Ulf de Faire4, Kerstin Elvin5, Bertil Lindahl6, Per Näsman7, Lars Ryden8, Anna Norrhammar9,10 and Elisabet Svenungsson11, 1Unit of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 2Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, 3Karolinska Institutet, Karolinska University Hospital, Cardiology Unit, Department of Medicine Solna, Stockholm, Sweden, 4Division of Cardiovascular Epidemiology IMM, Karolinska Institutet, Stockholm, Sweden, 5Dept. of Clinical Immunology and Transfusion Medicine, Unit of Clinical Immunology, Department of Medicine Solna, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 6Department Medical Sciences, Uppsala University, Uppsala, Sweden, 7Center for Safety Research, KTH Royal Institute of Technology, Stockholm, Sweden, 8Cardiology Unit, Department of Medicine Solna,, Karolinska Institutet, Stockholm, Sweden, 9Cardiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, 10Capio S:t Görans hospital, Stockholm, Sweden, 11Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden
Background/Purpose: The antiphospholipid syndrome (APS) is present when arterial, venous or microvascular thrombosis or obstetric morbidity concur with confirmed positive tests for antiphospholipid antibodies (aPL).…